Literature DB >> 6815411

Hematological changes in mice experimentally infected with Trypanosoma cruzi.

J E Cardoso, Z Brener.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 6815411     DOI: 10.1590/s0074-02761980000200009

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


× No keyword cloud information.
  10 in total

1.  The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.

Authors:  María Virginia Tribulatti; Juan Mucci; Nico Van Rooijen; María Susana Leguizamón; Oscar Campetella
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells.

Authors:  P Libby; J Alroy; M E Pereira
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

3.  Purinergic ecto-enzymes participate in the thromboregulation in acute in mice infection by Trypanosoma cruzi.

Authors:  Guilherme M do Carmo; Pedro H Doleski; Mariângela F de Sá; Thirssa H Grando; Nathieli B Bottari; Daniela B R Leal; Lucas T Gressler; Ricardo E Mendes; Lenita M Stefani; Silvia G Monteiro; Aleksandro S Da Silva
Journal:  Mol Cell Biochem       Date:  2017-03-11       Impact factor: 3.396

4.  Purinergic system ecto-enzymes participate in the thromboregulation of patients with indeterminate form of Chagas disease.

Authors:  Viviane do Carmo Gonçalves Souza; Karine B Schlemmer; Cristiano B Noal; Jeandre A S Jaques; Margarete D Bagatini; Victor C Pimentel; Luiz Felipe D Carli; Cláudio A M Leal; Juliana Fleck; Maria B Moretto; Maria R C Schetinger; Daniela B R Leal
Journal:  Purinergic Signal       Date:  2012-07-01       Impact factor: 3.765

5.  Alterations in the surface charge of heart muscle cells during interaction with Trypanosoma cruzi.

Authors:  M de N Soeiro; F Costa e Silva Filho; M de N Leal de Meirelles
Journal:  Cell Biophys       Date:  1995-02

6.  The TcI and TcII Trypanosoma cruzi experimental infections induce distinct immune responses and cardiac fibrosis in dogs.

Authors:  Ana Luiza Cassin Duz; Paula Melo de Abreu Vieira; Bruno Mendes Roatt; Rodrigo Dian Oliveira Aguiar-Soares; Jamille Mirelle de Oliveira Cardoso; Flávia Carvalho Bitencourt de Oliveira; Levi Eduardo Soares Reis; Washington Luiz Tafuri; Vanja Maria Veloso; Alexandre Barbosa Reis; Cláudia Martins Carneiro
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-12       Impact factor: 2.743

7.  Immunosuppression in Experimental Chagas Disease Is Mediated by an Alteration of Bone Marrow Stromal Cell Function During the Acute Phase of Infection.

Authors:  Uwe Müller; Günter A Schaub; Horst Mossmann; Gabriele Köhler; Rita Carsetti; Christoph Hölscher
Journal:  Front Immunol       Date:  2018-12-10       Impact factor: 7.561

8.  Oral Route Driven Acute Trypanosoma cruzi Infection Unravels an IL-6 Dependent Hemostatic Derangement.

Authors:  Dina Antunes; Alessandro Marins-Dos-Santos; Mariana Tavares Ramos; Barbara Angelica S Mascarenhas; Carlos José de Carvalho Moreira; Désio Aurélio Farias-de-Oliveira; Wilson Savino; Robson Q Monteiro; Juliana de Meis
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

9.  Host Genetics Background Influence in the Intragastric Trypanosoma cruzi Infection.

Authors:  Carolina Salles Domingues; Flávia de Oliveira Cardoso; Daiana de Jesus Hardoim; Marcelo Pelajo-Machado; Alvaro Luiz Bertho; Kátia da Silva Calabrese
Journal:  Front Immunol       Date:  2020-11-24       Impact factor: 7.561

10.  Oral exposure to Phytomonas serpens attenuates thrombocytopenia and leukopenia during acute infection with Trypanosoma cruzi.

Authors:  Rosiane V da Silva; Aparecida D Malvezi; Leonardo da Silva Augusto; Danielle Kian; Vera Lúcia H Tatakihara; Lucy M Yamauchi; Sueli F Yamada-Ogatta; Luiz V Rizzo; Sergio Schenkman; Phileno Pinge-Filho
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.